FDA COVID-19 NEWS RELEASE - Updated March 27, 2020

 FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 P

Human Research Protections (HRP) is a comprehensive program that affords protections for all human research participants and is under the direct leadership of the executive vice president and provost. This website is designed to provide users with the most up-to-date information related to conducting research with human participants.

Full Accreditation by AAHRP

Smart IRB Logo

Institutional Official (IO), Dr. Susan Buskirk

The IO is responsible for ensuring that the Human Research Protection Program (HRPP) functions effectively and that the institution provides the resources and support necessary to comply with all requirements applicable to research involving human subjects. 

UMB HRP Components

The main focus here is to provide information, resources, and instructions for completing the review process through the IRB. While the IRB is a key player in the HRP program, there are many other components within UMB critically involved in protecting human participants. Click here to learn more.

What Can Be Found Here

For Researchers: This resource helps investigators design, write, and organize research protocols; maintain compliance with policies and regulations; create and submit IRB applications via CICERO.

 

HRP Office: Information regarding its role in coordinating the Human Research Protections Program and providing support for the UMB Institutional Review Board (IRB). Contact information and informatics regarding submission processing times.

 

Institutional Review Board (IRB): Information about the board and the executive members and their role in approving, monitoring, and reviewing biomedical and behavioral research involving humans.

 

For Research Participants: This section assists former, current, or prospective human research participants in obtaining information or offering input regarding research and clinical trials.

Announcements

(Click for Past Announcements)

FDA NEWS RELEASE - Coronavirus (COVID-19) Update: FDA Issues Guidance for Conducting Clinical Trials

March 18, 2020  To access news release click here

UMB IRB and HRPO Guidance Regarding COVID19 and Conduct of Research

March 12, 2020  All Researchers - Please read the attached document for guidance regarding COVID-19 and the responsible conduct of active research. UMB IRB and HRPO Guidance Regarding COVID19 and Research


 

OHRP - New Lecture Video on e-Consent

OHRP Newsletter February 2020. OHRP is excited to announce that a new informative video on e-Consent is now available to the research community!